IRCT20180110038302N6招募中未知
Evaluation of the effectiveness of progressive muscle relaxation on maternal and neonatal outcomes on primiparous women with preeclampsia in Kamali hospital,Karaj, Iran 2019-2020
Alborz University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •primary parous women with 26-34 weeks gestational age
- •singleton pregnancy
- •non-severe preeclampsia criterias
- •low risk results in the frist and second trimester fetal screenings
- •persiane race and at least having reading and writing literacy
排除标准
- •physical and mental illnesses (such as cardio-respiratory disease, diabetes mellitus and gestational diabetes, seizure, depression, anxiety disorders ,etc)
- •history of infertility and/or repeated miscarriage
- •vaginal hemorrhage and/or leaking amniotic fluid and/or uterine contractions
- •recent severe stress and/or anxiety
- •intrauterine growth restriction
- •usage of alcohol and/or cigarettes and/or drugs
研究者
相似试验
招募中
不适用
The effect of progressive muscle relaxation on covid-19 anxiety in pregnant womeIRCT20200630047962N1Tehran University of Medical Sciences126
已完成
2 期
Effect of progressive muscle relaxation technique on fatigue in patientsChronic renal failureHemodialysis.IRCT2016092514333N59Vice chancellor for research, Kermanshah University of Medical Sciences60
已完成
不适用
Strength Training in Gestational Diabetes Mellitus (GDM)Gestational DiabetesMetabolic and Endocrine - DiabetesACTRN12605000378628International Diabetes Institute70
尚未招募
Unknown
Evaluation of the effectiveness of a continuous multidisciplinary follow-up model for functional recovery of post-intensive care patients.Post Intensive Care Syndromepostintensive care syndrome PICS Follow upMeSH Unique ID: C000657744JPRN-jRCT1032230546Takiguchi Chie800
进行中（未招募）
1 期
To evaluate the efficacy beyond progression of vemurafenib combined with cobimetinib associated with local treatment compared to second-line treatment in patients with BRAFV600 mutation-positive metastatic melanoma in focal progression with first-line combined vemurafenib and cobimetinib.BRAFV600 mutation-positive metastatic melanoma in focal progressionMedDRA version: 21.1Level: LLTClassification code 10053571Term: MelanomaSystem Organ Class: 100000004864EUCTR2017-003038-98-ITINTERGRUPPO MELANOMA ITALIANO120